Citation

BibTex format

@article{Silverberg:2024:10.1111/jdv.20388,
author = {Silverberg, JI and Mustapa, MN and Reid, F and Lei, A and Smith, R and Moate, R and Kelly, A and Chen, R and Gavala, M and Jimenez, E and Belvisi, MG and Sadiq, MW and Kell, C and Pandya, HC},
doi = {10.1111/jdv.20388},
journal = {JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY},
title = {Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2)},
url = {http://dx.doi.org/10.1111/jdv.20388},
year = {2024}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Silverberg,JI
AU  - Mustapa,MN
AU  - Reid,F
AU  - Lei,A
AU  - Smith,R
AU  - Moate,R
AU  - Kelly,A
AU  - Chen,R
AU  - Gavala,M
AU  - Jimenez,E
AU  - Belvisi,MG
AU  - Sadiq,MW
AU  - Kell,C
AU  - Pandya,HC
DO  - 10.1111/jdv.20388
PY  - 2024///
SN  - 0926-9959
TI  - Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2)
T2  - JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
UR  - http://dx.doi.org/10.1111/jdv.20388
ER  -
Download